Try our Advanced Search for more refined results
September 22, 2016
Amgen Inc. v. Amneal Pharmaceuticals et al
Case Number:
1:16-cv-00853
Court:
Nature of Suit:
Judge:
Firms
- Connolly Gallagher
- Cozen O'Connor
- Farnan LLP
- Heyman Enerio
- Morris James
- Morris Nichols
- Phillips McLaughlin
- Potter Anderson
- Prickett Jones
- Shaw Keller
- Stamoulis & Weinblatt
- White and Williams
Companies
- Alkem Laboratories Ltd.
- Allergan PLC
- Amgen Inc.
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Ascend Laboratories LLC
- Aurobindo Pharma Ltd.
- Breckenridge Pharmaceutical Inc.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- Micro Labs Ltd.
- Mylan NV
- Piramal Group
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 21, 2017
Breckenridge Admits Sensipar Generic Violates Amgen Patent
A Delaware federal judge on Thursday approved a settlement in which Breckenridge Pharmaceutical Inc. admitted it infringed Amgen Inc.'s patent for its calcium reducer Sensipar when it asked the U.S. Food and Drug Administration to approve generics before the patent expired.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login